Phio Pharmaceuticals Corp [NASDAQ: PHIO] traded at a high on Monday, posting a 26.70 gain after which it closed the day’ session at $2.23.
The results of the trading session contributed to over 11106037 shares changing hands. Over the past one week, the price volatility of Phio Pharmaceuticals Corp stands at 38.35% while the volatility over the past one month is 14.98%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for PHIO stock reached $2.38 million, with 1.06 million shares outstanding and 1.02 million shares in the current float. Compared to the average trading volume of 162.16K shares, PHIO reached a trading volume of 11106037 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Phio Pharmaceuticals Corp [PHIO]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PHIO shares is $36.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PHIO stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for Phio Pharmaceuticals Corp shares, keeping their opinion on the stock as Buy, with their previous recommendation back on August 05, 2020.
The Average True Range (ATR) for Phio Pharmaceuticals Corp is set at 0.39 The Price to Book ratio for the last quarter was 0.43, with the Price to Cash per share for the same quarter was set at 5.04.
How has PHIO stock performed recently?
Phio Pharmaceuticals Corp [PHIO] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -21.48. With this latest performance, PHIO shares dropped by -11.86% in over the last four-week period, additionally sinking by -65.88% over the last 6 months – not to mention a drop of -67.77% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for PHIO stock in for the last two-week period is set at 42.62, with the RSI for the last a single of trading hit 42.18, and the three-weeks RSI is set at 43.29 for Phio Pharmaceuticals Corp [PHIO]. The present Moving Average for the last 50 days of trading for this stock 2.7500, while it was recorded at 2.1900 for the last single week of trading, and 4.5800 for the last 200 days.
Phio Pharmaceuticals Corp [PHIO]: Deeper insight into the fundamentals
Phio Pharmaceuticals Corp’s liquidity data is similarly interesting compelling, with a Quick Ratio of 6.38 and a Current Ratio set at 6.38.
Insider trade positions for Phio Pharmaceuticals Corp [PHIO]
There are presently around $3.02%, or 3.17%% of PHIO stock, in the hands of institutional investors.
